Delivery Order SPE2DB20D1004-SPE2DB24FF3G9
- Not listed
- This federal contract award, valued at $3,764.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL pens. The contract is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.83 firm fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen, 3mL, a diabetes medication. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any special type of business. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,704.50, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL, a critical medication used in the management of diabetes. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Insulin Aspart 100 Unit/ML Pen 3ML to the U.S. Department of Defense (DoD) and its agencies. The $2,379.74 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to provide a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.56, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. This is a firm fixed-price delivery order contract with a completion date of January 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award, with a total ceiling value of $36,063.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order valued at $6,102.16 for INSULIN ASPART 100 UNIT/ML VL 10ML. The award was made by the Defense Logistics Agency (DLA), which is the primary logistics and material distribution provider for the U.S. military. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The U.S. government awarded a Delivery Order contract valued at $6,593.67 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Insulin Aspart 100 Unit/mL Pen 3mL to support federal healthcare programs. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,207.57, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a Firm Fixed Price type, with a period of performance through February 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of insulin aspart 100 unit/mL pens (3 mL) to the Defense Logistics Agency (DLA), a defense agency. The $6,552.33 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF3G9Delivery Order
This federal contract award, valued at $3,659.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML, a critical pharmaceutical product. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 1/30/24 |